trending Market Intelligence /marketintelligence/en/news-insights/trending/ZgIdbMjfk5udIMHRj8tESw2 content esgSubNav
In This List

Abeona Therapeutics prices common stock offering

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Abeona Therapeutics prices common stock offering

Abeona Therapeutics Inc. priced an underwritten public offering of 5 million shares at $16 apiece to raise $80 million in gross proceeds.

The company granted underwriters a 30-day option to buy up to an additional 750,000 of the shares offered.

The offering is expected to close by Oct. 19, with Jefferies LLC acting as the lead book-running manager.

Abeona Therapeutics plans to use net proceeds for working capital and corporate purposes.

RBC Capital Markets is the joint book runner and Cantor Fitzgerald & Co. is the lead manager of the issue.

FBR Capital Markets & Co., H.C. Wainwright & Co., JonesTrading Institutional Services LLC and Maxim Group LLC are acting as co-managers for the offering.